Article info

Download PDFPDF

Original research
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

Authors

  1. Correspondence to Dr Chuanhui Cao, Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China; huichuancao{at}163.com; Dr Jingyuan Sun, Department of Radiation Oncology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China; 15013050515{at}163.com
View Full Text

Citation

Sheng H, Huang Y, Xiao Y, et al
ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

Publication history

  • Accepted April 29, 2020
  • First published May 26, 2020.
Online issue publication 
May 26, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.